Home > Boards > US Listed > Biotechs > BioMarin Pharmaceutical Inc. (BMRN)

AstraZeneca added 14p to £32.92 as it announced

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
chmcnfunds Member Profile
 
Followed By 71
Posts 11,686
Boards Moderated 0
Alias Born 12/25/09
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2020 3:01:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/30/2020 2:12:01 PM
BioMarin Promotes Company Veteran, Brian R. Mueller, to Executive Vice President, CFO PR Newswire (US) - 6/29/2020 4:16:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/23/2020 7:25:40 PM
BioMarin to Participate in the Virtual BofA Securities 2020 Napa Biopharma Conference PR Newswire (US) - 6/23/2020 8:30:00 AM
uniQure Announces the Appointment of Leonard E. Post, Ph.D. to its Board of Directors GlobeNewswire Inc. - 6/17/2020 4:05:10 PM
BioMarin Provides Additional Data from Recent 4 Year Update of Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene The... PR Newswire (US) - 6/17/2020 9:20:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/9/2020 6:04:44 PM
BioMarin to Participate in Two Upcoming Virtual Investor Conferences PR Newswire (US) - 6/3/2020 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/1/2020 4:16:57 PM
BioMarin Provides Highlights of 4 Years of Clinical Data from Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Ther... PR Newswire (US) - 5/31/2020 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 6:49:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 6:33:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 6:08:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 5:39:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 5:10:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 4:51:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 4:37:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 4:24:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 4:14:29 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/19/2020 4:21:31 PM
BioMarin Announces Closing of Exercise by Initial Purchasers of Option to Purchase an Additional $50 million of 1.25% Senior ... PR Newswire (US) - 5/19/2020 4:15:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2020 4:19:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/12/2020 1:52:42 PM
BioMarin Announces Pricing of Upsized $550 Million Senior Subordinated Convertible Notes Offering PR Newswire (US) - 5/11/2020 11:26:00 PM
chmcnfunds   Tuesday, 11/12/13 10:03:29 AM
Re: None
Post # of 678 
AstraZeneca added 14p to £32.92 as it announced a £120m investment in its manufacturing site in Macclesfield. There was also renewed talk the company was interested in US group BioMarin Pharmaceutical, although many believed Swiss giant Roche could beat the UK group to the punch with a near $11bn offer.
________________________________________________________
http://www.theguardian.com/business/marketforceslive/2013/nov/11/ftse-100-higher-bskyb-rsa-insurance-fall

BMRN

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist